Your activity: 36 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Azelastine: Patient drug information

Azelastine: Patient drug information

Information for this drug is presented separately based upon the following methods of administration:

Topic 11107 Version 41.0